Vertex Pharmaceuticals Statistics
Total Valuation
VRTX has a market cap or net worth of $118.82 billion. The enterprise value is $110.97 billion.
| Market Cap | 118.82B |
| Enterprise Value | 110.97B |
Important Dates
The last earnings date was Thursday, February 12, 2026, after market close.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VRTX has 254.03 million shares outstanding. The number of shares has increased by 0.04% in one year.
| Current Share Class | 254.03M |
| Shares Outstanding | 254.03M |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | -0.58% |
| Owned by Insiders (%) | 0.23% |
| Owned by Institutions (%) | 95.50% |
| Float | 253.18M |
Valuation Ratios
The trailing PE ratio is 30.49 and the forward PE ratio is 24.37. VRTX's PEG ratio is 0.17.
| PE Ratio | 30.49 |
| Forward PE | 24.37 |
| PS Ratio | 10.17 |
| Forward PS | 9.23 |
| PB Ratio | 6.50 |
| P/TBV Ratio | 7.07 |
| P/FCF Ratio | 37.97 |
| P/OCF Ratio | 33.39 |
| PEG Ratio | 0.17 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.81, with an EV/FCF ratio of 34.75.
| EV / Earnings | 28.07 |
| EV / Sales | 9.25 |
| EV / EBITDA | 22.81 |
| EV / EBIT | 23.67 |
| EV / FCF | 34.75 |
Financial Position
The company has a current ratio of 2.90, with a Debt / Equity ratio of 0.11.
| Current Ratio | 2.90 |
| Quick Ratio | 2.24 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.40 |
| Debt / FCF | 0.64 |
| Interest Coverage | 352.44 |
Financial Efficiency
Return on equity (ROE) is 22.54% and return on invested capital (ROIC) is 29.61%.
| Return on Equity (ROE) | 22.54% |
| Return on Assets (ROA) | 12.16% |
| Return on Invested Capital (ROIC) | 29.61% |
| Return on Capital Employed (ROCE) | 21.52% |
| Weighted Average Cost of Capital (WACC) | 5.91% |
| Revenue Per Employee | $1.88M |
| Profits Per Employee | $617,688 |
| Employee Count | 6,400 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 3.85 |
Taxes
In the past 12 months, VRTX has paid $690.00 million in taxes.
| Income Tax | 690.00M |
| Effective Tax Rate | 14.86% |
Stock Price Statistics
The stock price has increased by +1.92% in the last 52 weeks. The beta is 0.32, so VRTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | +1.92% |
| 50-Day Moving Average | 460.82 |
| 200-Day Moving Average | 435.25 |
| Relative Strength Index (RSI) | 50.54 |
| Average Volume (20 Days) | 1,552,767 |
Short Selling Information
The latest short interest is 4.42 million, so 1.74% of the outstanding shares have been sold short.
| Short Interest | 4.42M |
| Short Previous Month | 4.42M |
| Short % of Shares Out | 1.74% |
| Short % of Float | 1.75% |
| Short Ratio (days to cover) | 3.04 |
Income Statement
In the last 12 months, VRTX had revenue of $12.00 billion and earned $3.95 billion in profits. Earnings per share was $15.32.
| Revenue | 12.00B |
| Gross Profit | 6.44B |
| Operating Income | 4.69B |
| Pretax Income | 4.64B |
| Net Income | 3.95B |
| EBITDA | 4.87B |
| EBIT | 4.69B |
| Earnings Per Share (EPS) | $15.32 |
Balance Sheet
The company has $6.61 billion in cash and $2.04 billion in debt, with a net cash position of $10.28 billion or $40.48 per share.
| Cash & Cash Equivalents | 6.61B |
| Total Debt | 2.04B |
| Net Cash | 10.28B |
| Net Cash Per Share | $40.48 |
| Equity (Book Value) | 18.67B |
| Book Value Per Share | 73.49 |
| Working Capital | 7.34B |
Cash Flow
In the last 12 months, operating cash flow was $3.63 billion and capital expenditures -$437.60 million, giving a free cash flow of $3.19 billion.
| Operating Cash Flow | 3.63B |
| Capital Expenditures | -437.60M |
| Free Cash Flow | 3.19B |
| FCF Per Share | $12.57 |
Margins
Gross margin is 53.67%, with operating and profit margins of 39.06% and 32.94%.
| Gross Margin | 53.67% |
| Operating Margin | 39.06% |
| Pretax Margin | 38.69% |
| Profit Margin | 32.94% |
| EBITDA Margin | 40.55% |
| EBIT Margin | 39.06% |
| FCF Margin | 26.61% |
Dividends & Yields
VRTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.04% |
| Shareholder Yield | -0.04% |
| Earnings Yield | 3.26% |
| FCF Yield | 2.63% |
Analyst Forecast
The average price target for VRTX is $526.79, which is 12.63% higher than the current price. The consensus rating is "Buy".
| Price Target | $526.79 |
| Price Target Difference | 12.63% |
| Analyst Consensus | Buy |
| Analyst Count | 27 |
| Revenue Growth Forecast (5Y) | 9.56% |
| EPS Growth Forecast (5Y) | 15.99% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 24, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Aug 24, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
VRTX has an Altman Z-Score of 11.93 and a Piotroski F-Score of 6.
| Altman Z-Score | 11.93 |
| Piotroski F-Score | 6 |